BioSpace News Archive

The heart and the circulatory systems followed by the nervous system is formed at the earliest stages of Fetus.

The Fact.MR market study on the veterinary artificial insemination Market provides deep dive into key developments in the veterinary artificial insemination Market.

The National Institutes of Biomedical Innovation, Health and Nutrition in partnership with Shionogi & Co. has successfully identified a novel antiviral antibody for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its variants, and closely associated coronavirus species.

Memo Therapeutics AG announced the close of an oversubscribed Series B financing round led by Swisscanto Invest at CHF37 million after securing an additional CHF23 million from a combination of strategic and financial investors, including Adjuvant Capital, Fresenius Medical Care Ventures, GF Group, Verve Ventures, Vesalius Biocapital and Zürcher Kantonalbank.

Sickle cell diseases are the conditions that are caused due to the abnormal shape and low flexibility of red blood cells, which are otherwise flexible and round, and the reduction of blood and oxygen caused as these irregularly shaped red blood cells cannot easily pass through blood vessels.

Oxaliplatin is anti-cancer medication indicated to treat colorectal cancer. It is a platinum-based drug belonging to the same family as that of cisplatin and carboplatin.

Typical ENT disorders include cholesteatoma, dizziness, dysphagia (difficulty swallowing), ear infection (otitis media), gastric reflux, hearing aids, and hearing loss.

Cyclotron is a class of devices that accelerates charged atomic or subatomic particles in a constant magnetic field.

Fact.MR – A Market research and competitive intelligence provider: The global oncology biosimilars market is projected to expand at a market size at a CAGR of 29.4% by 2025 end.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global Huntington’s disease treatment market was expected to attain market value of US$ 360 Mn in 2021.